Call9

Call9 aimed to provide on-demand medical advice to patients in home care settings, particularly nursing homes, using medical equipment and iPads instead of requiring 911 calls or emergency room visits. The company's core innovation was its "value-cared basis" payment model, where doctors' compensation was tied to patient satisfaction rather than a fixed fee. While this model aimed to align incentives with patient outcomes, it proved detrimental to physician retention and financial stability, as doctors' salaries became unpredictable. Call9's failure stemmed primarily from its unsustainable business model and potentially over-ambitious expansion. The "value-cared basis" model was a significant hurdle, as it directly impacted doctor compensation, making it difficult to retain medical professionals demanding consistent income. Furthermore, the US healthcare system's slow adoption of such innovative payment structures made it challenging for Call9 to integrate and thrive. Despite securing significant funding ($34M) and forming partnerships with companies like Lyft, Call9 expanded rapidly, planning to move beyond its Brooklyn base to Albany, NY, and operating a community paramedicine division. This rapid scaling likely exacerbated their financial struggles, hinting at a lack of profitability or efficient unit economics. The company eventually tried to pivot, focusing on technology in nursing homes and acquiring new partnerships. However, this shift was too late or insufficient to rescue the struggling startup. The narrative suggests that investors today have decreased patience, expecting quick results from their investments. Call9, despite its substantial funding, couldn't deliver the necessary outcomes fast enough, leading to its shutdown. This highlights the critical importance of validating a business model's profitability and scalability before aggressive expansion, especially in complex and regulated sectors like healthcare, where consumer and professional behavior change is slow.